Excenel Rtu Ez is a drug owned by ZOETIS INC. It is protected by 1 US drug patent filed in 2016. All patents have expired. Details of Excenel Rtu Ez’s patents and their expiration are given below.
| Drug Patent Number | Drug Patent Expiry | Status |
|---|---|---|
 | ||
| US5736151 | Active | |
Exclusivity Information
Excenel Rtu Ez holds 1 exclusivity out of which 1 has expired. Details of Excenel Rtu Ez's exclusivity codes and their expiration dates are given below.
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| NCI | May 06, 2022 |
Excenel Rtu Ez Petitions
Details of Excenel Rtu Ez's suitability petitions are listed below.
| Petitioner | Action | Date of Action | Description |
|---|---|---|---|
 | |||
| Cephazone Pharma LLC | Denied | NA | |
About Excenel Rtu Ez
Excenel Rtu Ez is a drug
owned by ZOETIS INC.
Excenel Rtu Ez uses
Ceftiofur Hydrochloride as the active
ingredient.
Active Ingredient:
Excenel Rtu Ez uses
Ceftiofur Hydrochloride as the active ingredient.
Check out other Drugs and Companies using
Ceftiofur Hydrochloride ingredient.